![]() |
市场调查报告书
商品编码
1858514
欧洲生物银行冷冻储存设备市场:分析与预测(2024-2033)Europe Biobanking Cold Storage Equipment Market: Analysis and Forecast, 2024-2033 |
||||||
2024 年欧洲生物银行恆温器市场规模为 5.914 亿美元,预计到 2033 年将达到 11.436 亿美元,在 2024-2033 年预测期内的复合年增长率为 7.60%。
为了促进基因组学、生物技术和製药领域的研究,对组织、血液和DNA等生物样本长期储存的需求日益增长,这推动了欧洲生物银行低温储存设备市场的发展。为了保持样本完整性并符合当地法规,欧洲生物样本库正越来越多地采用低温储存系统、超低温冷冻库和先进的冷冻设备。鑑于这些设备在维持生物样本品质方面发挥着至关重要的作用,其耗材、软体、服务和仪器等相关产品占据了市场的大部分份额。
| 关键市场统计数据 | |
|---|---|
| 预测期 | 2024-2033 |
| 2024年评估 | 5.914亿美元 |
| 2033年的预测 | 11.436亿美元 |
| 复合年增长率 | 7.6% |
随着温度监测、自动化和节能製冷技术的进步,储存的永续性和可靠性正在不断提高。在欧盟「地平线欧洲」等资助计画的支持下,该地区高度重视转化研究和个人化疗法,这推动了对高性能低温储存系统的强劲需求。更严格的生物银行和资料保护法规(ISO 20387、GDPR)也加速了安全合规储存基础设施的普及。欧洲持续引领生物银行库创新,在研发投入、临床试验和基因组数据产出的推动下,为样本保存、营运效率和低温保存技术的永续性制定了国际标准。
市场介绍
由于生物生物银行设施的扩展、精准医疗需求的日益增长以及基因组学和临床研究的兴起,欧洲生物银行冷冻保存设备市场正经历着稳步增长。遍布欧洲的生物样本库已成为DNA、组织、血液和细胞株等生物样本的重要储存库,以长期维持样本的完整性。这些样本需要先进的冷冻保存方法。这些系统,包括冷冻保存设备、自动化样本管理系统和超低温冷冻库,对于维持样本活性和支援后续研究应用至关重要。
强有力的政府支持、财政扶持以及诸如「地平线欧洲」(Horizon Europe)等旨在促进转化研究和生物医学创新的计划,都在推动市场成长。德国、英国、瑞典和法国是生物样本库建设的领先国家。这些国家重视标准化的储存流程和永续的低温运输管理。此外,传统的生物样本库运作正向数位化生态系统转型,更重视资料整合、自动化和物联网赋能的温度监控。对设备的需求持续增长,主要源于临床试验、生物标记鑑定和个人化治疗的日益增长的需求。凭藉其完善的医疗保健基础设施和监管体系,欧洲在生物样本保存的可靠性、永续性和创新性方面持续引领行业标准,使其成为生物银行冷冻保存技术的全球先驱。
市场区隔
细分:按地区
欧洲仍然是全球生物银行冷冻储存设备市场的领先地区。该地区拥有数量最多的生物样本库,这得益于其完善的医疗保健基础设施、对研发的高度重视以及政府对生命科学倡议的大力支持。英国、德国、法国和荷兰等国家是主要贡献者,它们在精准医疗、基因组学和生物医学研究领域投入大量资金。此外,欧洲对生物样本库严格的法规环境确保了对高品质冷冻储存解决方案的需求,进一步推动了市场成长。众多领先企业和研究机构的存在也巩固了欧洲在该市场的主导地位。
欧洲生物样本库低温储存设备市场趋势、驱动因素与挑战
市场趋势
市场驱动因素
市场挑战
本报告深入剖析了生物银行冷冻储存设备的最新进展,包括温度控制、自动化和云端基础监控系统等方面的创新。企业可以利用这些见解,发掘产品差异化机会,开发新一代冷冻储存解决方案,并整合最尖端科技,以满足生物样本库和个人化医疗日益增长的需求。
该报告深入分析了各个地区和细分市场,使企业能够瞄准生物样本库基础设施需求快速成长的高成长地区。了解市场趋势和区域动态将有助于企业调整行销策略,并在高成长地区有效定位其产品,以满足日益增长的先进冷冻保存解决方案的需求。
竞争策略:透过分析市场占有率、主要参与企业和产业趋势,企业可以评估竞争动态,识别市场领导,并制定策略以获得竞争优势,包括建立策略伙伴关係、进入新市场以及开发创新产品以满足生物样本库和研究机构不断变化的需求。
This report can be delivered in 2 working days.
Introduction to Europe Biobanking Cold Storage Equipment Market
The Europe biobanking cold storage equipment market was valued at $591.4 million in 2024 and is anticipated to reach $1,143.6 million by 2033, witnessing a CAGR of 7.60% during the forecast period 2024-2033. The growing demand for long-term preservation of biological samples, such as tissues, blood, and DNA, for enhanced research in genomics, biotechnology, and pharmaceuticals is propelling the market for biobanking cold storage equipment in Europe. To maintain sample integrity and adhere to local regulations, European biobanks are progressively implementing cryogenic storage systems, ultra-low temperature freezers, and sophisticated refrigeration units. Due to its crucial role in preserving biosample quality, equipment holds the greatest part of the market, which is divided into consumables, software, services, and equipment.
| KEY MARKET STATISTICS | |
|---|---|
| Forecast Period | 2024 - 2033 |
| 2024 Evaluation | $591.4 Million |
| 2033 Forecast | $1,143.6 Million |
| CAGR | 7.6% |
Storage sustainability and dependability are being improved by technological advancements in temperature monitoring, automation, and energy-efficient refrigeration. great-performance cold storage systems are in great demand due to the region's significant emphasis on translational research and customized treatment, which is backed by EU-funded programs like Horizon Europe. Adoption of safe, compliant storage infrastructure is also being fueled by more stringent biobanking and data protection laws (ISO 20387, GDPR). Europe continues to be a major center for biobanking innovation, setting international standards for sample preservation, operational effectiveness, and sustainability in cold storage technology with rising R&D expenditures, clinical trials, and genomic data output.
Market Introduction
The market for biobanking cold storage equipment in Europe is growing steadily due to the expansion of the biobanking infrastructure, the growing need for precision medicine, and the rise in genomic and clinical research. In order to maintain sample integrity for long-term usage, biobanks around Europe are crucial repositories for biological samples such DNA, tissues, blood, and cell lines. These samples require sophisticated cold storage methods. These systems, which include cryogenic storage units, automated sample management systems, and ultra-low temperature freezers, are essential for preserving sample viability and assisting with further research applications.
Strong government backing, financial initiatives, and projects like Horizon Europe that foster translational research and biomedical innovation all contribute to the market's growth. Leading nations in the establishment of biobanks include Germany, the United Kingdom, Sweden, and France; these nations place a strong emphasis on standardized storage procedures and sustainable cold chain management. Additionally, traditional biobanking operations are becoming smart, digitalized ecosystems due to the increased emphasis on data integration, automation, and IoT-enabled temperature monitoring. The demand for equipment is still being driven by the growing need for clinical trials, biomarker identification, and personalized treatment. Europe continues to be a global pioneer in biobanking cold storage technology, setting standards for dependability, sustainability, and innovation in biosample preservation thanks to its sophisticated healthcare infrastructure and regulatory alignment.
Market Segmentation:
Segmentation: by Region
Europe remains the leading region in the global biobanking cold storage equipment market. The region is home to the highest number of biobanks, driven by a robust healthcare infrastructure, a strong focus on research and development, and government support for life sciences initiatives. Countries like the U.K, Germany, France, and the Netherlands are key contributors, with substantial investments in precision medicine, genomics, and biomedical research. Additionally, Europe's strict regulatory environment for biobanks ensures the demand for high-quality cold storage solutions, further boosting market growth. The presence of major players and research institutions also strengthens Europe's dominant position in the market.
Europe Biobanking Cold Storage Equipment Market Trends, Drivers and Challenges:
Market Trends
Market Drivers
Market Challenges
How can this report add value to an organization?
Product/Innovation Strategy: This report provides valuable insights into the latest advancements in biobanking cold storage equipment, including innovations in temperature control, automation, and cloud-based monitoring systems. Organizations can use these insights to identify opportunities for product differentiation, develop next-generation cold storage solutions, and integrate cutting-edge technologies to meet the growing demands of biobanks and personalized medicine.
Growth/Marketing Strategy: The report offers detailed regional and market segment insights, enabling organizations to target high-growth, where demand for biobanking infrastructure is rapidly expanding. By understanding market trends and regional dynamics, companies can align their marketing strategies to effectively position their products in fast-growing regions, capitalizing on the increasing need for advanced cold storage solutions.
Competitive Strategy: By analyzing market share, key players, and industry trends, this report allows organizations to evaluate competitive dynamics, identify market leaders, and develop strategies to gain a competitive edge. This can include forming strategic partnerships, entering new markets, and developing innovative product offerings to meet the evolving needs of biobanks and research institutions.
Scope and Definition